NasdaqCM - Delayed Quote USD
Cyclacel Pharmaceuticals, Inc. (CYCC)
0.3700
-0.2350
(-38.84%)
At close: June 6 at 4:00:01 PM EDT
0.4200
+0.05
+(13.51%)
After hours: June 6 at 7:59:48 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Sing Ee Wong | Chairman, CEO & President | -- | -- | 1981 |
| Mr. Cu Seng Kiu | Executive Director, CFO & Secretary | -- | -- | 1990 |
| Ms. Gill Christie | Director of Human Resources | -- | -- | 1957 |
| Grace Kim | Investor Relations Executive | -- | -- | -- |
Cyclacel Pharmaceuticals, Inc.
Level 10
Tower 11 Avenue 5, No. 8 Jalan Kerinchi
Kuala Lumpur, 592000
Malaysia
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Corporate Governance
Cyclacel Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 12, 2025 at 10:59 AM UTC - August 18, 2025 at 12:00 PM UTC
Cyclacel Pharmaceuticals, Inc. Earnings Date
Recent Events
May 1, 2025 at 12:00 AM UTC
Dividend Date
April 28, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
Related Tickers
GLYC GlycoMimetics, Inc.
0.1938
-2.42%
CBUS Cibus, Inc.
1.6600
+7.10%
KAPA Kairos Pharma, Ltd.
0.4730
-5.87%
CDT Conduit Pharmaceuticals Inc.
2.6900
-0.37%
SILO Silo Pharma, Inc.
0.5811
-9.20%
CDIO Cardio Diagnostics Holdings, Inc.
4.7650
+5.42%
PLRZ Polyrizon Ltd.
0.8040
-5.01%
XLO Xilio Therapeutics, Inc.
0.7000
+3.20%
ABP Abpro Holdings, Inc.
0.2103
-0.94%
NCNA NuCana plc
0.0499
+26.33%